The Prevalence Of Gluten-sensitive Enteropathy In Iron-deficient Anemia Patients
Gluten sensitive enteropathy (GSE) is an autoimmune enteropathy due to food gluten intolerance in genetically predisposed people. While GSE was thought to be a rare disease in the past and was believed to be essentially a disease of Europeans, recent screening studies showed that GSE is one of the most frequent genetically based diseases occured worldwide.

Fungal Pill Could Provide Asthma Relief For 150,000 UK Sufferers
Up to 150,000 people suffering from severe asthma in the UK could benefit from taking antifungal medication already available from pharmacists, new research has found. University of Manchester scientists found that pills used to treat everyday fungal infections greatly improved symptoms of asthma in those patients that had an allergic reaction to one or more fungi.

GeneThera Will Test Milk And Dairy Products Due To Evidence Linking Johne's Disease To IBS And Crohn's Disease
GeneThera, Inc. (PINKSHEETS: GTHR) announced it will begin testing of raw and processed milk and dairy products using its Real Time PCR test for Johne's disease through its Wheat Ridge, CO laboratory.

NY City Health Department Launches Effort To Study Neighborhood Air Quality
The Health Department today announced the launch of the New York City Community Air Survey, the first comprehensive effort to monitor street level air pollution in neighborhoods across the five boroughs. Air pollution monitors mounted on 150 light posts throughout the city will be used to measure major air pollutants that contribute to health problems.

Nothing To Sneeze At: Real-time Pollen Forecasts - Journal Analytical Chemistry
Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air. Their study is in the current issue of ACS' Analytical Chemistry, a semi-monthly journal.

EPA Makes Decision To Designate Areas Not Meeting Standards For Fine Particle Pollution, USA
EPA has notified 25 governors and 23 tribal leaders that certain areas in their states and tribal lands do not meet the agency's daily standards for fine particle pollution, also known as PM 2.5. "These designations are an important step in our steady march toward cleaner air," said EPA Administrator Stephen L. Johnson. "We will continue working with our state and tribal partners to meet these air quality standards.

Nighttime Breathing Problems Not Necessarily Associated With Allergies
Snoring and daytime sleepiness are not associated with allergic rhinitis, but are associated with obstructed nasal passages, regardless of an individual's allergic status, according to an article released on December 15, 2008 in Archives of Otolaryngology--Head & Neck Surgery, one of the JAMA/Archives journals. One persistent symptom of allergic rhinitis, a runny nose due to allergies, is nasal obstruction.

Health Education Trust: Response To BMJonline 'This Allergies Hysteria Is Just Nuts'
HET has responded to this week's BMJOnline Article by Professor Christakis of Harvard Medical School regarding the sometimes over cautious approach taken by some schools to avoid allergy incidents and nut bans. The story has been covered too by the national press. Our recently launched Best Practice Guidance Toolkit for Secondary Schools takes an allergy-aware approach to addressing this serious issue, that may also help schools towards achieving nutritional compliance.

Anti-Allergy Vaccines To Help People With Asthma
Research funded by Asthma UK has led to the development of a vaccine treatment that can prevent asthma-like symptoms in mice. Dr Noble and his team at King's College London have been studying allergic mechanisms in mice and investigating whether it is possible to regulate the immune system's response to potential allergic triggers.

MU Entomologist Warns Of The Venomous Brown Recluse Spider's Bite
As the cold weather creeps in, so do brown recluse spiders. True to their name, the brown recluse is a shy, reclusive spider looking for a warm home. Drawn to clutter, closets and complex storage environments, the spiders actually want to stay away from humans. But, if care is not taken, people could find themselves sharing their home with one of 'the big three,' according to a University of Missouri entomologist.

Allergies Alone Not Associated With Increased Risk Of Nighttime Breathing Problems
Allergic rhinitis does not appear to be associated with snoring or daytime sleepiness, but individuals with obstructed nasal passages are likely to experience both regardless of whether they have allergies, according to a report in the December issue of Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journals.

Allergists Respond To FDA Committee Recommendation On Asthma Medication, Encourage Patients With Questions To Contact Physicians
The nation's allergists urged a Joint FDA Advisory Committee today to continue to make long-acting beta-2 agonists available for the treatment of moderate-to-severe asthma in appropriate patients.

REGiMMUNE Receives $12 Million In Grants To Develop Transplant And Allergy Drugs
REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, today announced that it has received two separate grants totaling more than $12 million from the Japan Science and Technology Agency (JST) and from National Institute of Biomedical Innovation (NIBIO).

Fear Of Nuts Creating Hysteria Of Epidemic Proportions
Measures imposed to reduce exposure to nuts are often based on irrational fears of nut allergies and are becoming increasingly sensationalist, according to a doctor on bmj.com today.

Start Of Phase IIb Clinical Study With CYT003-QbG10 Monotherapy For The Treatment Of Allergic Diseases
Cytos Biotechnology Ltd (SIX:CYTN) announced today that it has started a phase IIb clinical study with CYT003-QbG10, an allergen-independent immunotherapeutic product candidate for the treatment of allergy and asthma. The study is a randomized, double-blind, placebo-controlled, multicenter dose-finding study to evaluate the safety, tolerability and efficacy of two different doses of CYT003-QbG10. It will include 300 patients with rhinoconjunctivitis due to house dust mite allergy.